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Cardiac hypertrophy is an important risk factor for cardiac morbidity and mortality. To unravel the underlying pathogenic genetic pathways, we
hybridized left ventricular RNA from Transverse Aortic Constriction mice at 48 h, 1 week, and 2, 3, and 8 weeks after surgery to microarrays
containing a 15K fetal cDNA collection. Key processes involved an early restriction in the expression of metabolic genes, accompanied by
increased expression of genes related to growth and reactivation of fetal genes. Most of these genes returned to basal expression levels during the
later, compensated hypertrophic phase. Our findings suggest that compensated hypertrophy in these mice is established by rapid adaptation of the
heart at the cost of gene expression associated with metabolic activity, with only temporary expression of possible maladaptive processes.
Therefore, the transient early changes may reflect a beneficial response to pressure overload, as deterioration of cardiac hemodynamic function or
heart failure does not occur.
© 2006 Elsevier Inc. All rights reserved.Keywords: Cardiac hypertrophy; Transverse aortic constriction; Energy metabolism; Gene expression; MicroarrayThe heart is able to adapt to increased workload, injury, or
defects in contractile performance by increasing muscle mass.
Activation of intracellular signaling cascades results in cardiac
hypertrophy, which can be defined as an increase in heart size
resulting from the enlargement of existing cardiomyocytes
[1]. Whereas compensatory cardiac remodeling seems bene-
ficial at first, myocardial hypertrophy is recognized as an
important risk factor for cardiac morbidity and mortality [2].
Much research has focused on the identification of molecular
pathways and processes underlying cardiac hypertrophy [3].
A reactivation of fetal genes, such as natriuretic peptides
(Nppa, natriuretic peptide precursor type A or ANF, atrial
natriuretic factor), Myh7 (myosin, heavy polypeptide 7,
cardiac muscle, β or Myhc-b, β myosin heavy chain) and
α-skeletal actin [4,5], has been observed. In addition,⁎ Corresponding author. Fax: +31 43 3877877.
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doi:10.1016/j.ygeno.2006.04.012intracellular Ca2+ handling, apoptosis, extracellular matrix
deposition, and fibrosis also play an important role [3,6,7].
Furthermore, many experimental and clinical studies in the
hypertrophied and failing heart have reported changes in
energy metabolism [8–10]. Although a substantial number of
processes have been recognized to play an important role in
the sequel of events resulting in cardiac hypertrophy, it is
largely unknown how the expression of genes involved in this
process is phased in time and how the expression profiles are
mutually related.
To elucidate the alterations in cardiac gene expression
during the various phases of myocardial hypertrophy and to
assess the nature of the processes involved, we used global
gene expression profiling at different time points to monitor
thousands of different genes simultaneously. As a model for
cardiac hypertrophy, we used a Transverse Aortic Constric-
tion (TAC) mouse model, in which cardiac hypertrophy is
induced by pressure overload. Gene expression profiles were
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mice at 48 h, 1 week, and 2, 3, and 8 weeks after aortic
banding. Differentially expressed genes were further ana-
lyzed using Gene MicroArray Pathway Profiler (GenMapp)
[11], MAPPFinder [12], TXTGate [13], and Adaptive
Quality-Based Clustering (AQBC) [14] to identify the
nature of the processes up- or downregulated during the
development of cardiac hypertrophy induced by pressure
overload.
Results
Left ventricular hypertrophy in TAC mice
Either a TAC or a sham procedure was performed on 60
mice to be able to sacrifice 5 TAC and 5 sham-operated mice
at 48 h, 1 week, and 2, 3, 8, and 28 weeks after surgery.
Mortality rates due to the surgical procedure were 8% for
TAC and 16% for sham-operated mice. The majority of the
samples showed a 2:1 ratio of 28S to 18S ribosomal RNA
and an A260:A280 ratio of ∼2.0. This indicates good RNA
quality. For four samples (one TAC and two shams at 1 week
and one sham at 3 weeks) the yield and quality were
insufficient and these were excluded. We balanced the
number of TAC and sham mice for each time point.
Unfortunately, at the 1-week time point, for technical reasons,
only 2 sham-operated mice were available, while for all
others at least 3 were. TAC mice at 1 week and 2, 3, and
8 weeks showed a reproducible degree of hypertrophy
compared to sham mice: mean left ventricular mass (LVM)/
tibia length (TL) ratios increased by respectively 40, 33, 28,
and 34% (Table 1). TAC mice at 48 h did not show any
increase [15]. The hypertrophy model was validated by real-
time PCR for three genes known to be differentially
expressed during hypertrophy (Fig. 1). Nppa was upregulated
with the highest fold change at 1 week (13.0-fold). Pln
(phospholamban) was downregulated, with its peak value also
at 1 week (5.1-fold). Both genes were differentially expressed
at all time points, although fold changes decreased toward the
later hypertrophic phase. Myh7 showed a slight upregulation
at all time points. Our results showed that in this respect the
hypertrophic response of the TAC mice is comparable with
earlier reports on this model [15,16]. Echocardiographic
measurements in mice at 28 weeks after TAC showed noTable 1
Left ventricular mass and tibia length in TAC and sham mice
Time TAC
n LVM (mg) TL (mm) LVM/TL (mg/mm
48 h 4 90 ± 6 167 ± 2 0.54 ± 0.03
1 week 3 134 ± 11 167 ± 3 0.80 ± 0.06
2 weeks 3 130 ± 9 171 ± 2 0.76 ± 0.04
3 weeks 4 124 ± 18 166 ± 1 0.74 ± 0.11
8 weeks 3 133 ± 17 168 ± 2 0.79 ± 0.10
Values are means ± SD; TAC, Transverse Aortic Constriction; Time, time point after b
length.decrease in fractional shortening and no signs of heart failure.
In addition, lung weight was not increased in these mice.
Therefore, the conclusion can be drawn that the TAC
procedure in the Swiss mice resulted in compensated cardiac
hypertrophy due to pressure overload without deterioration of
cardiac hemodynamic function during the experimental period
of 8 weeks.
Quality of the microarray data
The positive controls (housekeeping genes) that were
spotted in several concentrations showed consistent intensities
throughout the slide. The negative controls (bacterial genes)
were negative. Next, we compared different probes on the
array representing the same gene (about 25% of the total
number of analyzed probes with a known LocusLink
Identifier (LL ID). When taking all time points together,
about 90% of the total number (1865) of genes represented by
more than one probe showed similar expression values, i.e.,
the fold change direction remains the same within a small
range. In addition, replicate hybridizations were performed for
five samples and these results showed that between-slide
variability (when possible adjusting for labeling efficiency
and spikes in the model) was close to zero. We feel that these
are criteria that prove high-quality data and overall
reproducibility.
As data from single genes are usually not sufficient to
draw a conclusion about a specific process, we also tested
the consistency with other genes involved in that process.
This will provide evidence for the role of the entire process
in the pathology observed. For part of the identified
processes, a total of seven genes were confirmed by real-
time PCR for all time points. Up- or downregulation of
Psen1 at 48 h (presenilin 1) could not be confirmed by
real-time PCR and upregulation of Tgfb1 (transforming
growth factor β1) at 8 weeks did not reach the level of
significance when measured by real-time PCR (Supplemen-
tary Table S1).
Number of differentially expressed genes in TAC mice
The total number of probes analyzed at 48 h, 1 week, and
2, 3, and 8 weeks was respectively 3066, 549, 4308, 6749,
and 6881 (Fig. 2). The low number at 1 week was due toSham
) n LVM (mg) TL (mm) LVM/TL (mg/mm)
4 92 ± 10 166 ± 5 0.55 ± 0.05
2 97 ± 5 169 ± 0 0.57 ± 0.03
3 99 ± 4 172 ± 2 0.57 ± 0.03
4 96 ± 7 167 ± 1 0.58 ± 0.04
3 101 ± 6 172 ± 2 0.59 ± 0.04
anding; n, number of animals in each group; LVM, left ventricle mass; TL, tibia
Fig. 1. Expression of hypertrophic markers in TAC mice at different time points after banding. Real-time PCR data are shown as the fold change (and confidence
interval) in the TAC mice relative to the expression levels of sham-operated mice. All hypertrophic markers were differentially expressed in the TAC mice.
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point and that the signal intensity of one of the slides was
low. This became apparent after the whole experiment and
analysis had been carried out. Although the remaining data
at 1 week are fewer in number, they are as reliable as the
data from the other time points (see the description of the
data analysis in the supplementary data) and represent
important processes. Therefore we have included them in
our detailed analysis of the altered processes. The number of
differentially expressed transcripts was largest at 48 h (454):
10.4% up- (215) and 13.8% downregulated (239). Most
genes showed a more than 2-fold difference in expression
and many genes more than 5- to 10-fold. At 1 week, 17.9%
were upregulated (65), whereas 1.1% were downregulated
(2). At 2 and 3 weeks, most genes were downregulated:
0.6% up (18) vs 5.5% down (162) and 0.8% up (35) vs.
2.7% down (130), respectively. At 8 weeks, both up- and
downregulated transcripts encompassed 2.8% of the analyzed
transcripts (144 up and 147 down). The majority of genes at
1 week and 2, 3, and 8 weeks showed a less than 2-fold
difference in expression. About 71% of the total number of
transcripts analyzed had a known LL ID (Fig. 2).
Significant processes in cardiac hypertrophy
The most important processes identified for all time
points, combining all tools, are shown in Table 2 and Fig.
3. Results for each analysis tool separately are shown in
Supplementary Table S2 (GenMAPP/MAPPFinder), S3
(TXTGate), and S5 (AQBC). Several previously reported
genes and processes involved in cardiac hypertrophy were
identified, e.g., Atp2a2 (sarcoplasmic reticulum Ca2+-
ATPase), Mapkapk2 (MAP kinase-activated protein kinase
2), and MAPK and G-protein signaling. At 48 h, a variety
of processes were identified, such as translation, signaling,response to heat and oxidative stress, proteolysis and
peptidolysis, fatty acid (FA) metabolism, and energy
conversion pathways as well as cytoskeletal, mitochondrial,
and ribosomal processes. Downregulation of metabolic
genes included genes involved in FA metabolism, the
tricarboxylic (TCA) cycle, and mitochondrial oxidative
phosphorylation (OXPHOS). At 1 week, genes involved in
energy metabolism were slightly upregulated, but returned
to normal levels at later stages (Supplementary Table S4). A
number of mitochondrial ribosomal genes and translation
initiation factors were up- as well as downregulated at 48 h
and 1 week. Cytoskeletal and sarcomeric genes were partly
down- and partly upregulated at 48 h, whereas all of these
genes analyzed at 1 week were upregulated. At 2, 3, and
8 weeks after banding, genes had returned to basal
expression levels again (Supplementary Table S4). With
TXTGate, we identified additionally the downregulation of
genes related to β-amyloid and the upregulation of genes
encoding proteins with kinase activity at 48 h and genes
involved in cancer/growth at 1 week after banding
(Supplementary Table S3). At 8 weeks, one cluster
consisted of genes present in the HUGE (Human Uniden-
tified Gene-Encoded) database and one of genes encoding
binding proteins.
The most prominent changes in processes as a reaction to
TAC occurred early and faded out at 2, 3, and 8 weeks
(Supplementary Table S4). Most of the later processes were
less drastic as far as alterations in gene activity are concerned.
Genes involved in TGFβ signaling seemed to be particularly
involved at 8 weeks and were mainly upregulated. At 48 h,
ubiquitin-activating and ubiquitin-conjugating enzymes, ubi-
quitin proteases, and ubiquitin ligases were up- and down-
regulated, while at the later time points these genes were
mainly downregulated (Supplementary Table S5). AQBC
analysis (Supplementary Table S5) did not provide additional
Fig. 2. Distribution of the numbers of probes analyzed per time point. “Total probes analyzed” represents the number of transcripts that qualified for analysis, divided
into known and unknown LocusLink IDs (LL). “Diff. Expr.” represents the total number of transcripts that are differentially expressed at each of the time points,
divided into down- and upregulated genes in the TAC mice. Finally, the actual number of genes represented by the transcripts with a known LL is indicated.
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point and only very few genes were differentially expressed at
more than one time point.
Discussion
Analysis of gene expression data
Increased LVM/TL ratios and differentially expressed
hypertrophy markers in left ventricular tissue of TAC mice
confirmed cardiac hypertrophy due to the aortic banding
procedure. After exclusion of all poor, negative, and empty
spots (flagged by ImaGene), about 7500 probes showed a
detectable expression. This is more or less the expected
percentage of genes expressed in the heart [16,17]. The
expression values of the genes were judged by strict criteria
(see supplementary data). At least two values per group (TAC
and sham) per time point should be available. Using linear
regression analysis, it was possible to detect small changes at
a statistically reliable level, even using only Cy3 labeling.
Not all of these small changes will be biologically relevant,
but if more genes involved in the same process show a
similar behavior, this provides additional evidence for a
significant role for that process [18]. Several differentiallyexpressed genes that lack additional information, such as the
“Riken cDNA clones” or “expressed sequences,” were
discarded from further analysis, but will be studied in the
future. The microarray results were validated in a number of
ways, such as consistent expression of different transcripts for
the same gene and real-time PCR confirmation, demonstrat-
ing the reliability of the microarray data. Comparable results
of real-time PCR validation have been reported by others
[19,20].
Early and transient alterations in expression of genes encoding
metabolic and cytoskeletal proteins
The most striking differences in gene expression were
observed for energy metabolism and cytoskeleton. Genes
encoding proteins involved in glycolysis, FA metabolism,
and mitochondrial processes such as the TCA cycle and
respiratory chain were in general downregulated at 48 h. In
contrast, genes involved in mitochondrial protein import and
mitochondrial protein synthesis were found to be upregu-
lated. This most likely reflects an initial downregulation of
genes involved in energy conversion pathways in favor of
the expression of genes for anabolic processes such as
mitochondriogenesis. The simultaneous increase in a number
Table 2
Most important processes and categories of genes identified using GenMAPP
(including MAPPFinder) and TXTGate
Category or process Tool
GenMAPP TXTGate
Acetyl-CoA metabolism X X
Alcohol metabolism X
DNA metabolism X
RNA metabolism X
Protein metabolism X
Carbohydrate metabolism X
Carboxylic acid metabolism X
Fatty acid metabolism X
Glycogen metabolism X
Lipid metabolism X
Glycolysis and gluconeogenesis X X
Mitochondrion X X
Energy pathways X X
Electron transport chain X X
Tricarboxylic cycle X X
Cell proliferation X
Cell cycle X
Growth X X
Cancer X
G-protein signaling X
TGFβ signaling X
MAPK signaling X X
Wnt signaling X
Transcription X
Immune response X
Response to heat X
Response to oxidative stress X
Ribosomal X X
Protein biosynthesis X
Translation X X
Protein degradation X X
Cytoskeleton organization and biogenesis X X
Development X
β-Amyloid metabolism X
Bone remodeling X
Calcium ion binding X
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translational initiation factor 2) at 48 h supports this
contention and may indicate that the first response to
TAC also occurs at the level of translation. Moreover,
changes in gene expression at 1 week could be an
indication of increased glycolytic activity of the heart at
this time point. In addition, the mainly increased expression
of cytoskeletal genes indicates a switch to renewed growth.
This was most evident at 1 week, which is in line with the
increased left ventricular mass 1 week after TAC.
Adjustment of structure and size of myofibrils is an early
response to cope with increased workload. This emphasizes
the physiological changes during early cardiac hypertrophy,
since the increase in cardiomyocyte size requires an
adaptation in cytoarchitecture.
Recently, Wagner and co-workers published the results of
a microarray study performed in hearts of TAC mice at one
single time point, i.e., 20 days after aortic banding [21].
They consider the processes identified in their study as
maladaptive, among which a downregulation of severalmetabolic genes, since cardiac hypertrophy can lead to heart
failure. In this respect it is worth noting that some studies
have reported a shift in substrate preference from FA to
glucose in mice that could precipitate the development of
heart failure [22]. It has been proposed that if the reduction
of FA oxidation is not fully compensated for by the
increased glucose oxidation, the overall rate of ATP
regeneration will decline, eventually leading to energy
starvation and decrease in cardiac performance [8]. Howev-
er, other investigators have not identified this shift or even
showed an increase in the use of FA in the hypertrophied
heart [8,10]. Moreover, overexpression of Glut1 (glucose
transporter 1) was reported to prevent the development of
heart failure due to chronic pressure overload by increasing
myocardial glucose uptake and thus represents a beneficial
adaptation [23]. Glut1 was not present in our cDNA
collection, but upregulation of Stx4a (syntaxin 4A, required
for Glut8 (glucose transporter 8) translocation) in the mice
at 1 week after TAC supports these findings. The results
from Wagner and colleagues regarding changes in expres-
sion of genes encoding proteins involved in energy
metabolism and cytoskeletal remodeling are similar to
ours. However, the strength of our approach is the
investigation of more than one time point, enabling us to
demonstrate that during the later hypertrophic phases (2, 3,
and 8 weeks), gene expression in these processes returns to
basal levels again.
In summary, the observed changes in expression of genes
involved in energy metabolism most likely reflect a
transition to temporary growth of the myocardium as an
adaptation to the increase in pressure overload and do not
necessarily represent a maladaptive process. The increased
expression of structural and sarcomeric genes may provide
important cytoskeletal support for the hearts of the aorta-
banded Swiss mice, such that hypertrophy does not progress
to failure, not even in the long term in this particular
experimental model.
Other significant processes during the early phase of cardiac
hypertrophy
Reexpression of fetal genes was identified at 48 h: not only
Nppa, Myh7, Pln, and Nrap (nebulin-related anchoring protein)
were differentially expressed, but also several other embryonic
genes. Melk (maternal embryonic leucine zipper kinase) is a
member of the Snf1/AMPK serine/threonine kinase family and
has so far been implicated only in mammalian embryogenesis,
with the highest expression during maturation of oocytes and
preimplantation development [24]. In addition, Hoxb3 (homeo-
box 3), Mfng (manic fringe homolog, Drosophila), Tdgf1
(teratocarcinoma-derived growth factor 1), and Cul1 (cullin 1)
were differentially expressed. These findings reflect the
activation of fetal gene expression in cardiac hypertrophy,
which may be cause or consequence of the renewed growth
[4,5].
Several genes associated with β-amyloid metabolism
showed a downregulation during the initial hypertrophic
Fig. 3. Schematic overview of the most important processes identified at the different time intervals after TAC. FA, TCA, and OXPHOS refer to fatty acid metabolism,
citric acid cycle, and oxidative phosphorylation, respectively. TGFβ refers to tissue growth factor β.
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(amyloid β (A4) precursor-like protein 2). β-Amyloid is a
small piece of the larger protein App, of which the normal
function has not yet been determined. Another gene present in
the cluster of β-amyloid-related genes was Itmb2, which has
been associated with familial British dementia [25]. It has
been reported before that coronary artery disease and
hypertension may be a forerunner to Alzheimer disease
[26], and recently another link between hypertrophy and
Alzheimer disease has been proposed in hypertrophic mice
after treatment with Ang II [27]. The precise roles of these
genes in the hypertrophic process remain, however, to be
elucidated.
Furthermore, processes such as transcription; cell growth;
development; signaling; nucleobase, nucleoside, nucleotide,
and nucleic acid metabolism (e.g., DNA and RNA metab-
olism); translation; protein biosynthesis; and protein degra-
dation contained a significant number of differentially
expressed genes at distinct time intervals after TAC. The
number of genes that were differentially expressed at more
than one time point was very low, which combined with the
high number of genes that was differentially expressed at
only one time point, also reported by Zhao et al. [16],
suggests that processes either are stage specific or, more
likely, may not be primarily related to the hypertrophy
process in the compensated state.
Changes occurring at the later (compensated) hypertrophic
phase
Although the changes in gene expression were much more
pronounced during the acute phase (48 h) and at 1 week after
TAC, we also identified several genes not previously reported
as hypertrophy-related genes during the later hypertrophic
phase, such as Cetn2 (centrin 2) and Plxnb1 (plexin b),
respectively up- and downregulated at 8 weeks. Activation of
signaling pathways such as G-protein signaling, MAPK
signaling, Wnt signaling, and TGFβ signaling was identified
at the different time points, although genes related to TGFβsignaling were slightly upregulated only at 8 weeks after
banding. Differences in gene expression were only modest at
these later time points and the differentially expressed genes
could less easily be grouped into certain processes. A direct
relation to the hypertrophic process remains therefore
questionable.
Conclusions
Although alterations in gene expression in response to
changes in the hemodynamic environment of the heart have
been reported previously [21,28,29], these studies were
restricted to only a few genes or to one particular time
point. In our study, compensated hypertrophy is character-
ized by an initial, but temporary, restriction in the
expression of genes encoding myocardial energy metabolism
in the early prehypertrophic phase associated with an
investment in the expression of genes involved in the
construction of the cytoskeletal and sarcomeric apparatus to
deal with the increased workload. The full establishment of
cardiac hypertrophy 1 week after aortic constriction is
associated with an upregulation of genes involved in
glycolytic activity and activation of fetal gene expression.
The fact that the hearts of TAC mice do not show signs of
overt failure, as assessed 28 weeks after aortic banding,
strongly suggests that the observed (transient) alterations in
gene expression are most likely beneficial rather than
detrimental in nature. Additional studies should be per-
formed to evaluate the functional consequences of these
changes.
Further cross-comparisons of different mouse models (with
or without transition to heart failure) will allow a more
detailed insight into these underlying processes and pathways
depending on the genetic or etiologic origins of hypertrophy
and heart failure. TAC has also been reported to lead to
decompensated hypertrophy or induction of heart failure,
likely influenced by animal species or strain differences
between the mice [30,31]. Therefore, comparisons of different
mouse strains may also reveal modifier genes that could
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phenotypic expression of hypertrophy and heart failure in
patients. Whether the processes identified by these studies
will be useful for prognosis in the clinical setting remains to
be determined. Time series experiments are an important
aspect in these comparisons, as the eventual outcome will
determine the conclusions regarding the adaptive or maladap-
tive nature of certain genes and the processes they are
involved in.Materials and methods
TAC mice
A total of 60 male inbred Swiss mice (10 weeks of age, body wt 27–35 g)
were randomly allocated to the TAC and sham-operation groups. Mice were
anesthetized with a combination of ketamine (100 mg/kg intramuscularly) and
xylazine (5 mg/kg subcutaneously). TAC was performed as described by
Rockman et al. [15]. Sham-operated mice underwent an identical surgical
procedure without the actual constriction of the aorta. All procedures were
performed in accordance with the recommendations of the Guide for the Care
and Use of Laboratory Animals published by the U.S. National Institutes of
Health (NIH Publication No. 85-23, revised 1996) and approved by the
Committee for Animal Research of Maastricht University. Mice were sacrificed
at 48 h, 1 week, and 2, 3, and 8 weeks after surgery. Hearts were harvested,
weighed, and frozen in liquid nitrogen. Hypertrophy was assessed by
determining the ratio LVM/TL. In a subset of animals (TAC, n = 5; sham, n =
5), cardiac function was assessed with echocardiography at 28 weeks following
the intervention.
Microarray preparation
In general, the microarray experiments were performed according to the
MIAME (Minimum Information about a Microarray Experiment) recommenda-
tions [32]. The cDNA inserts from the NIA (National Institute on Aging) Mouse
15K cDNA collection, derived from embryonic and fetal cells and tissues [33],
were PCR amplified directly from the glycerol stocks. The insert sizes of eight
clones per 96-well plate were verified as a quality check. After purification, PCR
products were resuspended at a concentration of 200 ng/μl in 50% DMSO and
spotted onto UltraGAPS coated slides (Corning) using the Microgrid II arrayer
(Biorobotics). This arrayer is mounted with a 16-pin head and slides were
printed in three separate runs. Each slide consisted of three metagrids,
subdivided in 16 subgrids, corresponding to the area printed by each pin.
Each subgrid has 20 rows and columns, yielding 400 spots per subgrid, 6400 per
metagrid.Table 3
Primers used for real-time PCR analysis
Gene symbol GenBank Acc. No. Sequence forward prim
Nppa K02781 5′-AGGAGAAGATGC
Myh7 NM_080728 5′-AGAACAAACTGA
Pln NM_023129 5′-CCTTCCTGGCATA
Psen1 NM_008943 5′-TCAAGAAAGCGT
App NM_007471 5′-AGCTCCTTCCCG
Nrap NM_008733 5′-GGCTAGTCCTGT
Idh3a NM_029573 5′-TGCCGAGGTGGA
Eno1 NM_023119 5′-AGTGACCAACCC
Uck2 NM_030724 5′-TCTCCAAGCGGC
Tgfb1 NM_011577 5′-TGGAAAGGGCCC
Plxnb1 NM_172775 5′-TGAGGACGTCAC
Sdhc NM_025321 5′-ACAAATGGTCTC
Ppia NM_008907 5′-CAAATGCTGGACThe total of 19,200 spots consisted of 15,120 cDNA clones and 4080
controls. Five positive controls (i.e., housekeeping genes) were spotted six times
by each pin in every metagrid. Three negative controls (i.e., bacterial genes) and
DMSO were spotted four times by every pin in each of the three metagrids.
Finally, 15 spots were left empty in each of the 16 subgrids of the three
metagrids. Each of these products was spotted in positions chosen uniformly
across the subgrid and therefore the slide.
RNA extraction, labeling, and hybridization
Total left ventricular RNA was extracted using the TRIzol reagent
(Invitrogen) and purified with the RNeasy Clean-Up kit (Qiagen). RNA quality
was determined with the Bioanalyser (Agilent). As the Cy5 dyes have been
reported to be unstable at high amounts of atmospheric ozone [34], we decided
to use only Cy3 labeling and compare the samples hybridized on different slides.
Reproducibility was checked by performing replicate hybridizations for five
samples. Aminoallyl labeling and RNA hybridization were performed according
to the protocol by Hegde et al. [35] and slightly adjusted for use in our own
laboratory. Briefly, 10 μg of total RNA from each sample was reverse
transcribed into cDNA using random primers in the presence of aminoallyl
dUTP. Following purification, products were coupled to Cy3 NHS-ester
(Amersham). Labeled cDNAs were purified and labeling efficiency was
determined. Slides were prehybridized in 1% bovine serum albumin, 50%
formamide, 5× SSC, and 0.1% SDS for 45 min at 42°C and then washed and
dried. The labeled cDNA was resuspended in 60 μl hybridization mix,
containing 50% formamide, 5× SSC, 0.1% SDS, and 8 μg mouse CotI DNA and
hybridized to the arrays at 42°C for 16 h. Slides were washed 4 min at 42°C in
1× SSC/0.2% SDS, 4 min at room temperature in 0.1× SSC/0.2% SDS, and
finally 4 min at room temperature in 0.1× SSC. Slides were dried by
centrifugation for 5 min at 500 rpm and scanned with a dual-laser scanner
(Affymetrix/GMS 418).
Microarray analysis
Images were quantified with ImaGene software (BioDiscovery). Any
probe that was flagged as empty, negative, or poor or had fewer than two
observations left per TAC or sham group was excluded from further analysis.
A more detailed description of this analysis is shown in the supplementary
data. Briefly, the remaining genes were analyzed using a Gaussian linear
regression including the labeling efficiency and, when necessary, the repeats.
The inference criterion used for comparing the models is their ability to
predict the observed data, i.e., models are compared directly through their
minimized minus log-likelihood. When the numbers of parameters in models
differ, they are penalized by adding the number of estimated parameters, a
form of the Akaike information criterion (AIC) [36]. For each gene, the
treatment group was then added to the model. The gene under consideration
was found to be differentially expressed if the AIC decreased compared to the
model not containing the treatment.er Sequence reverse primer
CGGTAGAAGA-3′ 5′-GCTTCCTCAGTCTGCTCACTCAG-3′
GGCGTGGG-3′ 5′-CCAGTGCCTTTCCGAACAAT-3′
ATGGAAA-3′ 5′-CATGTTGCAGGTCTGGAGTG-3′
TGCCAGC-3′ 5′-CGTGGCGAAGTAGAACACGA-3′
TGAATGG-3′ 5′-ACCCCAAAAGGGTGCCA-3′
CGGAGCC-3′ 5′-CTTCTGAGTAAACCTGGCCACAT-3′
GCTGAC-3′ 5′-AACACAGGCCCCCGCT-3′
TAAGCGGA-3′ 5′-GCAAGAGGCAGTTGCAGGAC-3′
AGACG-3′ 5′-ACGCCTGCCTCTTGCG-3′
AGCAC-3′ 5′-GCAATAGTTGGTATCCAGGGCT-3′
TTCCGAACT-3′ 5′-GCCACCGTTGCTCCATCT-3′
TTCCTATGGCA-3′ 5′-CCCCTCCACTCAAGGCTATTC-3′
CAAACACAA-3′ 5′-GCCATCCAGCCATTCAGTCT-3′
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meantime replaced by GeneID). The genes analyzed and fold changes were
loaded into GenMapp [11] and MAPPFinder [12] to evaluate the transcripts in
relation to known biological processes, molecular function, and cellular
component based on Gene Ontology terms and to obtain a ranked list (using
p < 0.05) of pathways with differentially expressed genes. To reveal unknown
relations between genes, we used the TXTGate Web service, which clusters
genes using literature-based information [13]. In addition, the expression profile
of the differentially expressed genes in time was investigated using Adaptive
Quality-Based Clustering [14]. This interface is intended to find groups of genes
that have similar expression profiles.
Real-time PCR
Real-time quantitative PCR (TaqMan, Applied Biosystems) was performed
using the SYBR Green PCR Core Reagents (Applied Biosystems). Reverse
transcription into cDNA was performed in a 40-μl volume with 1.25 μg total
RNA as a template. After denaturing at 65°C for 10 min, the RNA, the first-
strand buffer, 1.25 mM dNTPs, 200 U Superscript II (Invitrogen), RNAsin, and
a mixture of 0.75 μg oligo(dT) primer and 0.75 μg random primers (Invitrogen)
were incubated for 1 h at 42°C followed by 5 min at 95°C. Primers were created
using Primer Express software (Applied Biosystems) based on GenBank
sequences (Table 3). The cDNA was amplified in duplo in 20 μl SYBR Green
PCR buffer, with 4 mM MgCl2, 1.25 mM dNTP mix, 0.25 U AmperaseUNG,
0.625 U AmpliTaq Gold DNA polymerase, and 1.25 pmol of the forward or
reverse primer. PCR conditions were, first, 50°C for 2 min, 95°C for 10 min,
followed by 40 cycles of 95°C for 15 s/60°C for 1 min. Next, samples were
heated to 95°C for 15 s, cooled at 60°C for 1 min, and then heated to 95°C in
20 min, followed by cooling to 4°C to create a dissociation curve to check for
nonspecific amplification. In addition, serial dilutions from the cDNA were
analyzed for each target gene to assess PCR efficiency. Transcription values
were related to the housekeeping gene Ppia (peptidylprolyl isomerase A or
cyclophilin). The results were analyzed using a Gaussian linear regression,
similar to the microarray analysis, with the adjustment of adding Ppia as a
housekeeping gene. The AIC was also used to assess whether there was a
difference between the controls and TAC mice (group effect). Hence, the gene
under consideration was found to be differentially expressed if the AIC
decreased compared to the model not containing the group difference.
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